Welcome to another blog, hope you all are doing fine. “Raised cholesterol levels” is something that many of you must have heard of. Many of you are well aware of the fact that high level of fats in your blood are bad for your health. But why are they actually bad, what can they do to your body and what can you do about them. To know about all this, you have to read this blog, lets get started.
Dyslipidemia is one of the most important modifiable risk factors for cardiovascular disease, the leading cause of death worldwide. It refers to abnormal levels of lipids (fats) in the blood, including elevated cholesterol, elevated triglycerides, elevated low-density lipoprotein (LDL) cholesterol, and/or reduced high-density lipoprotein (HDL) cholesterol.
Dyslipidemia significantly increases the risk of:
Coronary artery disease
Myocardial infarction (heart attack)
Ischemic stroke
Peripheral arterial disease
Chronic kidney disease
Premature cardiovascular death
The increasing prevalence of obesity, diabetes mellitus, metabolic syndrome, sedentary lifestyles, and unhealthy dietary habits has made dyslipidemia a major public health challenge worldwide.
Fortunately, early diagnosis and evidence-based treatment can dramatically reduce cardiovascular morbidity and mortality.
What Is Dyslipidemia?
Dyslipidemia is a disorder characterized by abnormal concentrations of lipids or lipoproteins in the bloodstream.
The abnormalities may include:
Elevated LDL Cholesterol
Known as “bad cholesterol.”
High LDL promotes atherosclerosis and cardiovascular disease.
Elevated Triglycerides
Excess triglycerides increase the risk of:
Cardiovascular disease
Acute pancreatitis (especially when >500 mg/dL)
Low HDL Cholesterol
HDL is often called “good cholesterol.”
Low HDL levels are associated with increased cardiovascular risk.
Elevated Non-HDL Cholesterol
Represents all atherogenic lipoproteins and is increasingly used as a treatment target.
Understanding Lipid Metabolism
Lipids are transported through the bloodstream in the form of lipoproteins.
Chylomicrons
Transport dietary triglycerides from the intestine.
Very Low-Density Lipoprotein (VLDL)
Produced by the liver.
Mainly transports triglycerides.
Intermediate Density Lipoprotein (IDL)
Intermediate product formed during VLDL metabolism.
Low-Density Lipoprotein (LDL)
Carries cholesterol to tissues.
Excess LDL accumulates within arterial walls and promotes plaque formation.
High-Density Lipoprotein (HDL)
Removes excess cholesterol from tissues and arteries and transports it back to the liver.
This process is known as reverse cholesterol transport.
Dyslipidemia: epidemiology
Dyslipidemia affects hundreds of millions of individuals worldwide.
The prevalence continues to increase due to:
Obesity epidemic
Type 2 diabetes mellitus
Physical inactivity
Increased consumption of processed foods
Aging populations
Many affected individuals remain undiagnosed because dyslipidemia is often asymptomatic.
Dyslipidemia: classification
Primary (Genetic) Dyslipidemia
Results from inherited abnormalities affecting lipid metabolism.
Examples include:
Familial Hypercholesterolemia
Characterized by markedly elevated LDL cholesterol.
Associated with premature coronary artery disease.
Familial Combined Hyperlipidemia
Common inherited disorder causing elevated LDL and triglycerides.
Familial Hypertriglyceridemia
Predominantly elevated triglyceride levels
Secondary Dyslipidemia
Caused by underlying medical conditions or medications.
Causes of Secondary Dyslipidemia
Obesity
One of the most common causes.
Type 2 Diabetes Mellitus
Often associated with:
Elevated triglycerides
Reduced HDL
Small dense LDL particles
Metabolic Syndrome
Strongly linked to dyslipidemia
Hypothyroidism
Can significantly elevate LDL cholesterol.
Chronic Kidney Disease
Produces multiple lipid abnormalities
Nephrotic Syndrome
Associated with severe hypercholesterolemia.
Liver Disease
Can alter lipid metabolism.
Pregnancy
May temporarily increase lipid levels.
Excessive Alcohol Consumption
Often causes hypertriglyceridemia.
Medications Associated with Dyslipidemia
Corticosteroids
Thiazide diuretics
Beta-blockers
Estrogens
Retinoids
Antiretroviral drugs
Some antipsychotic medications
Risk Factors
Major risk factors include:
Increasing age
Family history of premature cardiovascular disease
Obesity
Diabetes mellitus
Hypertension
Smoking
Sedentary lifestyle
Unhealthy diet
Chronic kidney disease
Dyslipidemia: pathophysiology
The primary consequence of dyslipidemia is atherosclerosis.
Step 1: Endothelial Injury
Hypertension, smoking, diabetes, and inflammation damage the vascular endothelium.
Step 2: LDL Infiltration
LDL particles enter the arterial wall.
Step 3: LDL Oxidation
LDL becomes oxidized and highly inflammatory.
Step 4: Foam Cell Formation
Macrophages ingest oxidized LDL and become foam cells.
Step 5: Fatty Streak Formation
Fatty streaks represent the earliest visible atherosclerotic lesions.
Step 6: Plaque Formation
Progressive inflammation leads to plaque development.
Step 7: Plaque Rupture
Plaque rupture can result in:
Acute myocardial infarction
Ischemic stroke
Sudden cardiac death
Dyslipidemia: symptoms
Dyslipidemia itself usually causes no symptoms.
Most patients are diagnosed during routine screening
Physical Signs
Xanthelasma
Yellow cholesterol deposits around the eyelids.
Tendon Xanthomas
Commonly affect:
Achilles tendon
Extensor tendons of the hands
Often suggest familial hypercholesterolemia.
Corneal Arcus
Gray-white ring around the cornea.
Particularly significant in younger patients.
Eruptive Xanthomas
Small yellow papules associated with severe hypertriglyceridemia.
Dyslipidemia: complications
Coronary Artery Disease
Most important complication.
Myocardial Infarction
High LDL cholesterol significantly increases risk.
Stroke
Atherosclerotic cerebrovascular disease may lead to ischemic stroke.
Peripheral Arterial Disease
Causes:
Claudication
Limb ischemia
Acute Pancreatitis
Severe hypertriglyceridemia (>500–1000 mg/dL) markedly increases risk.
Dyslipidemia: diagnosis/investigations
Lipid Profile
The cornerstone of diagnosis.
Measured parameters include:
Total Cholesterol
Desirable: <200 mg/dL
LDL Cholesterol
Optimal: <100 mg/dL
Very high-risk patients often require substantially lower targets.
HDL Cholesterol
Men: >40 mg/dL
Women: >50 mg/dL
Triglycerides
Normal: <150 mg/dL
Non-HDL Cholesterol
Increasingly used in risk assessment.
Additional Laboratory Evaluation
Evaluate for secondary causes:
Fasting glucose
HbA1c
TSH
Liver function tests
Cardiovascular Risk Assessment
Modern guidelines recommend assessing overall cardiovascular risk rather than treating lipid numbers alone.
Important factors include:
Age
Sex
Smoking status
Blood pressure
Diabetes
Cholesterol levels
Family history
Dyslipidemia: treatment
Lifestyle Modification
Lifestyle intervention is the foundation of therapy.
Dietary Recommendations
Reduce Saturated Fats
Limit:
Butter
Ghee
Fatty red meat
Processed meat
Avoid Trans Fats
Common sources:
Fried foods
Commercial baked products
Increase Fiber Intake
Excellent sources include:
Oats
Fruits
Vegetables
Legumes
Whole grains
Mediterranean Diet
Strongly recommended.
Includes:
Olive oil
Fish
Vegetables
Fruits
Nuts
Whole grains
Associated with reduced cardiovascular events.
Physical Activity
Recommended:
At Least 150 Minutes Weekly
Moderate-intensity aerobic exercise such as:
Brisk walking
Cycling
Swimming
Weight Reduction
Weight loss improves:
LDL cholesterol
Triglycerides
HDL cholesterol
Insulin resistance
Pharmacological Treatment
Statins
First-line therapy.
Examples:
Atorvastatin
Rosuvastatin
Simvastatin
Pravastatin
Benefits:
Lower LDL cholesterol
Stabilize plaques
Reduce cardiovascular mortality
Ezetimibe
Reduces intestinal cholesterol absorption.
Often added when LDL targets are not achieved with statins alone.
PCSK9 Inhibitors
Examples:
Evolocumab
Alirocumab
Can reduce LDL cholesterol by more than 50%.
Used in:
Familial hypercholesterolemia
Very high-risk cardiovascular patients
Bempedoic Acid
Useful for selected patients who cannot tolerate statins.
Fibrates
Examples:
Fenofibrate
Gemfibrozil
Primarily lower triglycerides
Omega-3 Fatty Acids
Particularly useful for severe hypertriglyceridemia
Management of Hypertriglyceridemia
Mild to Moderate (150–499 mg/dL)
Treatment focuses on:
Lifestyle modification
Weight loss
Diabetes control
Severe (≥500 mg/dL)
Primary goal:
Prevent acute pancreatitis.
Treatment may include:
Fibrates
Omega-3 fatty acids
Strict dietary fat restriction
Prevention
Effective preventive measures include:
Healthy diet
Regular exercise
Weight management
Smoking cessation
Blood pressure control
Diabetes management
Routine lipid screening
I hope after reading this blog you now know why we need to keep our cholesterol levels in check and if they are not under control what we need to do. I hope you find this blog useful. goodbye.Weight Loss and Obesity: Causes, Risks, Diagnosis, Treatment, Diet, Exercise, Medications, and Prevention ( an overview ) Beginning of a series.